{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T19:38:13Z","timestamp":1790883493589,"version":"4.1.0"},"reference-count":115,"publisher":"Informa UK Limited","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Future Oncol."],"published-print":{"date-parts":[[2010,4,30]]},"DOI":"10.2217\/fon.10.18","type":"journal-article","created":{"date-parts":[[2010,4,7]],"date-time":"2010-04-07T14:25:00Z","timestamp":1270650300000},"page":"619-634","source":"Crossref","is-referenced-by-count":48,"title":["Oncolytic Herpes Simplex Virus Vectors and Chemotherapy: Are Combinatorial Strategies More Effective for Cancer?"],"prefix":"10.1080","volume":"6","author":[{"given":"Ryuichi","family":"Kanai","sequence":"first","affiliation":[{"name":"Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital, & Harvard Medical School, Boston, MA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Wakimoto","sequence":"additional","affiliation":[{"name":"Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital, & Harvard Medical School, Boston, MA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tooba","family":"Cheema","sequence":"additional","affiliation":[{"name":"Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital, & Harvard Medical School, Boston, MA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel D","family":"Rabkin","sequence":"additional","affiliation":[{"name":"Brain Tumor Research Center, Department of Neurosurgery, Massachusetts General Hospital, & Harvard Medical School, Boston, MA, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2010,4,7]]},"reference":[{"key":"e_1_3_3_3_1_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2008.02.001"},{"key":"e_1_3_3_3_2_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300108"},{"key":"e_1_3_3_3_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2007.05.005"},{"key":"e_1_3_3_3_4_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1851332"},{"key":"e_1_3_3_3_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301377"},{"key":"e_1_3_3_3_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0736"},{"key":"e_1_3_3_3_7_1","first-page":"2501","volume-title":"Fields Virology (5th Edition)","author":"Roizman B","year":"2007","unstructured":"Roizman B , KnipeDM, WhitleyRJ. Herpes simplex viruses. In: Fields Virology (5th Edition). KnipeDM, HowleyPM (Eds). Wolters Kluwer Health\/Lippincott Williams & Wilkins, PA, USA, 2501\u20132601 (2007)."},{"key":"e_1_3_3_3_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700537"},{"key":"e_1_3_3_3_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700946"},{"key":"e_1_3_3_3_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0995-938"},{"key":"e_1_3_3_3_11_1","first-page":"419","article-title":"Viral vectors as therapeutic agents for glioblastoma.","volume":"7","author":"Aghi M","year":"2005","unstructured":"Aghi M , RabkinS: Viral vectors as therapeutic agents for glioblastoma.Curr. Opin. Mol. Ther.7, 419\u2013430 (2005).","journal-title":"Curr. Opin. Mol. Ther."},{"key":"e_1_3_3_3_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jamcollsurg.2007.06.333"},{"key":"e_1_3_3_3_13_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.228"},{"key":"e_1_3_3_3_14_1","first-page":"356","article-title":"Overcoming the extracellular matrix barrier to improve intratumoral spread and therapeutic potential of oncolytic virotherapy.","volume":"10","author":"Yun CO","year":"2008","unstructured":"Yun CO : Overcoming the extracellular matrix barrier to improve intratumoral spread and therapeutic potential of oncolytic virotherapy.Curr. Opin. Mol. Ther.10, 356\u2013361 (2008).","journal-title":"Curr. Opin. Mol. Ther."},{"key":"e_1_3_3_3_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302038"},{"key":"e_1_3_3_3_16_1","doi-asserted-by":"publisher","DOI":"10.2174\/156800907780058907"},{"key":"e_1_3_3_3_17_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.24.3675"},{"key":"e_1_3_3_3_18_1","first-page":"371","article-title":"Virus combinations and chemotherapy for the treatment of human cancers.","volume":"10","author":"Kumar S","year":"2008","unstructured":"Kumar S , GaoL, YeagyB, ReidT: Virus combinations and chemotherapy for the treatment of human cancers.Curr. Opin. Mol. Ther.10, 371\u2013379 (2008).","journal-title":"Curr. Opin. Mol. Ther."},{"key":"e_1_3_3_3_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1462-5822.2009.01317.x"},{"key":"e_1_3_3_3_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/cr900048k"},{"key":"e_1_3_3_3_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm0697-639"},{"key":"e_1_3_3_3_22_1","doi-asserted-by":"publisher","DOI":"10.1038\/78638"},{"key":"e_1_3_3_3_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301512"},{"key":"e_1_3_3_3_24_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302436"},{"key":"e_1_3_3_3_25_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700585"},{"key":"e_1_3_3_3_26_1","first-page":"555","article-title":"A Phase I\/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma.","volume":"9","author":"Hecht JR","year":"2003","unstructured":"Hecht JR , BedfordR, AbbruzzeseJLet al.: A Phase I\/II trial of intratumoral endoscopic ultrasound injection of ONYX-015 with intravenous gemcitabine in unresectable pancreatic carcinoma.Clin. Cancer Res.9, 555\u2013561 (2003).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_3_3_27_1","doi-asserted-by":"publisher","DOI":"10.2174\/156800907780058817"},{"key":"e_1_3_3_3_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.23052"},{"key":"e_1_3_3_3_29_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-2008"},{"key":"e_1_3_3_3_30_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2009.01289.x"},{"key":"e_1_3_3_3_31_1","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-8-47"},{"key":"e_1_3_3_3_32_1","first-page":"3342","article-title":"Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.","volume":"6","author":"Coukos G","year":"2000","unstructured":"Coukos G , MakrigiannakisA, KangEH, RubinSC, AlbeldaSM, Molnar-KimberKL: Oncolytic herpes simplex virus-1 lacking ICP34.5 induces p53-independent death and is efficacious against chemotherapy-resistant ovarian cancer.Clin. Cancer Res.6, 3342\u20133353 (2000).","journal-title":"Clin. Cancer Res."},{"key":"e_1_3_3_3_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.neo.7900016"},{"key":"e_1_3_3_3_34_1","doi-asserted-by":"publisher","DOI":"10.1089\/hum.2006.17.1241"},{"key":"e_1_3_3_3_35_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djj003"},{"key":"e_1_3_3_3_36_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1090"},{"key":"e_1_3_3_3_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/0065-2571(84)90007-4"},{"key":"e_1_3_3_3_38_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.58.3.10"},{"key":"e_1_3_3_3_39_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-09-1947"},{"key":"e_1_3_3_3_40_1","first-page":"173","article-title":"Evaluating response to antineoplastic drug combinations in tissue culture models.","volume":"110","author":"Reynolds CP","year":"2005","unstructured":"Reynolds CP , MaurerBJ: Evaluating response to antineoplastic drug combinations in tissue culture models.Methods Mol. Med.110, 173\u2013183 (2005).","journal-title":"Methods Mol. Med."},{"key":"e_1_3_3_3_41_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-007-0567-8"},{"key":"e_1_3_3_3_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0065-3527(06)69002-7"},{"key":"e_1_3_3_3_43_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.virusres.2009.06.016"},{"key":"e_1_3_3_3_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7701049"},{"key":"e_1_3_3_3_45_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-3145"},{"key":"e_1_3_3_3_46_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm229"},{"key":"e_1_3_3_3_47_1","doi-asserted-by":"publisher","DOI":"10.2174\/156652309789753329"},{"key":"e_1_3_3_3_48_1","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950016410"},{"key":"e_1_3_3_3_49_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1209053"},{"key":"e_1_3_3_3_50_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.75.15.7050-7058.2001"},{"key":"e_1_3_3_3_51_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.700"},{"key":"e_1_3_3_3_52_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2005.06.024"},{"key":"e_1_3_3_3_53_1","doi-asserted-by":"publisher","DOI":"10.1096\/fj.02-1080fje"},{"key":"e_1_3_3_3_54_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ju.0000164730.38431.5c"},{"key":"e_1_3_3_3_55_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.185"},{"key":"e_1_3_3_3_56_1","doi-asserted-by":"publisher","DOI":"10.2217\/fon.09.7"},{"key":"e_1_3_3_3_57_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.5.1.2237"},{"key":"e_1_3_3_3_58_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4628"},{"key":"e_1_3_3_3_59_1","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2009.10"},{"key":"e_1_3_3_3_60_1","first-page":"1038","article-title":"Enhanced efficacy of herpes simplex virus mutant HF10 combined with paclitaxel in peritoneal cancer dissemination models.","volume":"54","author":"Shimoyama S","year":"2007","unstructured":"Shimoyama S , GoshimaF, TeshigaharaOet al.: Enhanced efficacy of herpes simplex virus mutant HF10 combined with paclitaxel in peritoneal cancer dissemination models.Hepatogastroenterology54, 1038\u20131042 (2007).","journal-title":"Hepatogastroenterology"},{"key":"e_1_3_3_3_61_1","first-page":"1508","article-title":"Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma.","volume":"63","author":"Cinatl J","year":"2003","unstructured":"Cinatl J Jr , CinatlJ, MichaelisMet al.: Potent oncolytic activity of multimutated herpes simplex virus G207 in combination with vincristine against human rhabdomyosarcoma.Cancer Res.63, 1508\u20131514 (2003).","journal-title":"Cancer Res."},{"key":"e_1_3_3_3_62_1","doi-asserted-by":"publisher","DOI":"10.1089\/10430349950018832"},{"key":"e_1_3_3_3_63_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-1657"},{"key":"e_1_3_3_3_64_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2006.07.032"},{"key":"e_1_3_3_3_65_1","doi-asserted-by":"publisher","DOI":"10.1089\/107999004323034097"},{"key":"e_1_3_3_3_66_1","doi-asserted-by":"publisher","DOI":"10.1080\/00016480601075381"},{"key":"e_1_3_3_3_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2008.03.037"},{"key":"e_1_3_3_3_68_1","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.22185"},{"key":"e_1_3_3_3_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.155"},{"key":"e_1_3_3_3_70_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0803988105"},{"key":"e_1_3_3_3_71_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2006.07.009"},{"key":"e_1_3_3_3_72_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.58"},{"key":"e_1_3_3_3_73_1","doi-asserted-by":"publisher","DOI":"10.1038\/cgt.2008.81"},{"key":"e_1_3_3_3_74_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2926"},{"key":"e_1_3_3_3_75_1","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.80.7.3341-3348.2006"},{"key":"e_1_3_3_3_76_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-1013"},{"key":"e_1_3_3_3_77_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3302770"},{"key":"e_1_3_3_3_78_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.mt.6300038"},{"key":"e_1_3_3_3_79_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-10-117457"},{"key":"e_1_3_3_3_80_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-009-0987-8"},{"key":"e_1_3_3_3_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2006.12.001"},{"key":"e_1_3_3_3_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/nbt0598-444"},{"key":"e_1_3_3_3_83_1","first-page":"2159","article-title":"Antitumor activity of a selectively replication competent herpes simplex virus (HSV) with enzyme prodrug therapy.","volume":"29","author":"Braidwood L","year":"2009","unstructured":"Braidwood L , DunnPD, HardyS, EvansTR, BrownSM: Antitumor activity of a selectively replication competent herpes simplex virus (HSV) with enzyme prodrug therapy.Anticancer Res.29, 2159\u20132166 (2009).","journal-title":"Anticancer Res."},{"key":"e_1_3_3_3_84_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700182"},{"key":"e_1_3_3_3_85_1","doi-asserted-by":"publisher","DOI":"10.1002\/jgm.1085"},{"key":"e_1_3_3_3_86_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cgt.7700978"},{"key":"e_1_3_3_3_87_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-0154"},{"key":"e_1_3_3_3_88_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2009.06.014"},{"key":"e_1_3_3_3_89_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0605496103"},{"key":"e_1_3_3_3_90_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-1087"},{"key":"e_1_3_3_3_91_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10776"},{"key":"e_1_3_3_3_92_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.49"},{"key":"e_1_3_3_3_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.chom.2006.12.001"},{"key":"e_1_3_3_3_94_1","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2008.240"},{"key":"e_1_3_3_3_95_1","doi-asserted-by":"publisher","DOI":"10.1517\/14728222.12.5.637"},{"key":"e_1_3_3_3_96_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg2634"},{"key":"e_1_3_3_3_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semradonc.2008.11.002"},{"key":"e_1_3_3_3_98_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-08-3886"},{"key":"e_1_3_3_3_99_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0004235"},{"key":"e_1_3_3_3_100_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-009-9926-0"},{"key":"e_1_3_3_3_101_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4402269"},{"key":"e_1_3_3_3_102_1","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-72-3-631"},{"key":"e_1_3_3_3_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3301885"},{"key":"e_1_3_3_3_104_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1072-7515(01)00866-3"},{"key":"e_1_3_3_3_105_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00705-002-0944-x"},{"key":"e_1_3_3_3_106_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.101136398"},{"key":"e_1_3_3_3_107_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.2173860"},{"key":"e_1_3_3_3_108_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.62.1.196-205.1988"},{"key":"e_1_3_3_3_109_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-3227"},{"key":"e_1_3_3_3_110_1","doi-asserted-by":"publisher","DOI":"10.1089\/104303402320138998"},{"key":"e_1_3_3_3_111_1","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.61.9.2896-2901.1987"},{"key":"e_1_3_3_3_112_1","first-page":"1502","article-title":"Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.","volume":"57","author":"Andreansky S","year":"1997","unstructured":"Andreansky S , SoroceanuL, FlotteERet al.: Evaluation of genetically engineered herpes simplex viruses as oncolytic agents for human malignant brain tumors.Cancer Res.57, 1502\u20131509 (1997).","journal-title":"Cancer Res."},{"key":"e_1_3_3_3_113_1","doi-asserted-by":"publisher","DOI":"10.1186\/1743-422X-5-68"},{"key":"e_1_3_3_3_114_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-6193"},{"key":"e_1_3_3_4_2_1","unstructured":"National Cancer Institute: clinical trials www.cancer.gov\/clinicaltrials"}],"container-title":["Future Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/fon.10.18","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T06:42:18Z","timestamp":1719124938000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/fon.10.18"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,4,7]]},"references-count":115,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,4,30]]}},"alternative-id":["10.2217\/fon.10.18"],"URL":"https:\/\/doi.org\/10.2217\/fon.10.18","relation":{},"ISSN":["1479-6694","1744-8301"],"issn-type":[{"value":"1479-6694","type":"print"},{"value":"1744-8301","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,4,7]]}}}